IFG
PPH icon

Independent Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Independent Financial Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Buy
5,373
+255
+5% +$26.4K 0.01% 921
2026
Q1 		$532K Buy
5,118
+84
+2% +$8.95K 0.01% 907
2025
Q4 		$519K Sell
5,034
-183
-4% -$17.8K 0.01% 880
2025
Q3 		$471K Buy
5,217
+8
+0.2% +$701 0.01% 883
2025
Q2 		$458K Sell
5,209
-492
-9% -$42.6K 0.01% 814
2025
Q1 		$520K Buy
5,701
+78
+1% +$7.03K 0.02% 694
2024
Q4 		$485K Buy
5,623
+1,668
+42% +$151K 0.02% 702
2024
Q3 		$376K Sell
3,955
-142
-3% -$13.5K 0.01% 776
2024
Q2 		$375K Sell
4,097
-552
-12% -$49.3K 0.02% 733
2024
Q1 		$422K Buy
4,649
+1,341
+41% +$117K 0.02% 643
2023
Q4 		$269K Buy
3,308
+290
+10% +$22.7K 0.01% 766
2023
Q3 		$241K Buy
3,018
+390
+15% +$31.4K 0.02% 761
2023
Q2 		$207K Buy
+2,628
New +$206K 0.01% 805

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Independent Financial Group's PPH Position: Q2 2026 in Review

Independent Financial Group increased its VanEck Pharmaceutical ETF (PPH) stake by 5% in Q2 2026, buying an estimated $26.4K and bringing the position to 5,373 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #921.

Independent Financial Group first reported a position in PPH in Q2 2023 and has held it in 13 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Independent Financial Group held 5,373 shares of VanEck Pharmaceutical ETF worth $588K as of Q2 2026.
  • Independent Financial Group bought 255 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $26.4K.
  • VanEck Pharmaceutical ETF made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #921 holding.
  • Independent Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 13 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.